ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

DY vs TMO // OPERATING MARGIN

Dycom Industries Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: DY 5 — TMO 7
▲ OPERATING MARGIN LEADER: TMO
operating-margins
6.20%
operating-margins
17.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DY VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC DY TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 6.80% 9.30% -2.50 TMO /roic <GO>
EV/EBITDA & P/E Valuation 17.0x 30.4x -13.40 DY /valuation <GO>
Free Cash Flow Yield 5.56% 2.40% +3.16 DY /fcf-yield <GO>
Operating Margin ACTIVE 6.20% 17.40% -11.20 TMO /operating-margins <GO>
Net Profit Margin 5.10% 15.10% -10.00 TMO /net-margins <GO>
Revenue Growth (YoY) 17.90% 3.90% +14.00 DY /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity 2.86 4.50 -1.64 TMO /balance-sheet <GO>
Piotroski F-Score Quality 8/9 8/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 40.0 62.9 -22.90 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.07 0.94 +0.13 DY /macro-sensitivity <GO>
Forward P/E Multiple 21.6x 36.3x -14.70 DY /forward-pe <GO>
Enterprise Scale & Market Cap $7.23B $262.22B -$254.99B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR DY REV TMO REV DY GROSS % TMO GROSS % DY FCF TMO FCF
FY 2025 $5.55B $44.56B — — $401.7M $6.29B
FY 2024 $4.70B $42.88B — — $98.6M $7.27B
FY 2023 $4.18B $42.86B — — $71.1M $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DY // BETA 1.07
TMO // BETA 0.94